Featured in this Issue
Fed Up with Drug Companies, Hospitals Decide to Start Their Own
A group of large hospital systems plans to create a nonprofit generic drug company to battle shortages and high prices
By Reed Abelson and Katie Thomas, The New York Times*
For years, hospital executives have expressed frustration when essential drugs like heart medicines have become scarce, or when prices have skyrocketed because investors manipulated the market.
Now, some of the country’s largest hospital systems are taking an aggressive step to combat the problem: They plan to go into the drug business themselves, in a move that appears to be the first on this scale.
Also in this Issue
- Performance:
- S&P 500 vs. Public Medical Service Companies
- S&P 500 vs. Public Medical Product Companies
- S&P 500 vs. Public Pharmaceutical and Biotechnology Companies
- Revenue Earning Pharmaceutical Companies
- Pre-Revenue Earning Pharmaceutical Companies
- Revenue Earning Biotechnology Companies
- Pre-Revenue Earning Biotechnology Companies
- Medical Devices
- Supplies and Equipment
- Diagnostics, Laboratories, and Tools
- Technology and IT
- Provider Services
- Other Service
- M&A Activity in Healthcare and Life Sciences
- Recent and Notable Healthcare Industry Transactions*
Selected Healthcare Transactions Q4 2018 - FOCUS Healthcare and Life Sciences Transactions
Oops! We could not locate your form.
